HEIDI BOBEK: Open Payments
NPI 1225218316 · HILLIARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 10 payments from 9 companies in 2025. Trend: 2023 $371 · 2024 $64 · 2025 $445
Food & beverage: $257Education: $188
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 2 | $117 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| GENZYME CORPORATION | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Octapharma USA, Inc. | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: DUPIXENT, Veozah, TEZSPIRE, NUCALA, OCTAGAM IMMUNE GLOBULIN (HUMAN), Xhance.
Industry payments across OH — which companies pay providers there.
